Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Course Director
Jonathan I. Silverberg, MD, PhD, MPH
Northwestern University Feinberg School of Medicine
Northwestern Medicine Multidisciplinary Eczema Center
Northwestern Memorial Hospital
Chicago, Illinois, USA
Accredited by
Medical Learning Institute, Inc.
View Activity Materials
Activity Details
| Credit Types: | CME/MOC/CE/CPE |
| Credit Amount: | 0.5 CME/MOC/CPE 1.0 CE |
| Release Date: | 2018-April-03 |
| Expiration Date: | 2019-April-02 |
| Estimated Time for Completion: | 30 minutes |
| Registration Required: | No |
| Cost: | Free of charge |
Activity Description and Educational Objectives
In this activity, a renowned dermatologist utilizes a novel storytelling approach to examine the diagnosis and treatment of patients with atopic dermatitis within the context of current evidence.
Upon completion of this activity, participants will be able to:
- Use evidence-based approaches to diagnose atopic dermatitis in clinical practice
- Apply key data sets on the efficacy and safety for novel treatments when selecting therapy for adult patients with atopic dermatitis
- Employ evidence-based, patient-centered approaches to managing adult patients with atopic dermatitis
Target Audience
This activity has been designed to meet the educational needs of dermatologists, allergists/immunologists, nurses, nurse practitioners, physician assistants, pharmacists, and other clinicians involved in the treatment of patients with atopic dermatitis.
Nursing Education Purpose Statement
The purpose of this activity is to improve knowledge and competence of nurses concerning the treatment of atopic dermatitis.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/MOC/CE/CPE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC/CE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Enduring Material
Release and Expiration Dates: April 03, 2018 - April 02, 2019
Time to Complete: 30 minutes
Faculty & Disclosure / Conflict of Interest Policy
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/MOC/CE/CPE activity during the past 12 months.
Course Director
Jonathan I. Silverberg, MD, PhD, MPH
Director, Northwestern Medicine Multidisciplinary Eczema Center
Director, Contact Dermatitis Clinic, Northwestern Memorial Hospital
Assistant Professor, Departments of Dermatology, Preventive Medicine and Medical Social Sciences
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Jonathan I. Silverberg, MD, PhD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant for AbbVie Inc.; Eli Lilly and Company; Galderma Laboratories, L.P.; GlaxoSmithKline; Kiniksa Pharmaceuticals; LEO Pharma Inc.; Menlo Therapeutics Inc.; Pfizer Inc.; Realm Therapeutics; Regeneron/sanofi-aventis U.S. LLC; and Roivant Sciences Ltd.
Grant/Research Support from GlaxoSmithKline (Funds to institution).
Speakers Bureau participant with Regeneron/sanofi-aventis U.S. LLC.
Advisory Board for AbbVie Inc.; Eli Lilly and Company; Galderma Laboratories, L.P.; GlaxoSmithKline; Kiniksa Pharmaceuticals; LEO Pharma Inc.; Menlo Therapeutics Inc.; Pfizer Inc.; Realm Therapeutics; Regeneron/sanofi-aventis U.S. LLC; and Roivant Sciences Ltd.
Jonathan I. Silverberg, MD, PhD, MPH, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: atopic dermatitis.
CME Reviewer
Kaushal Patel, MD
Internal Medicine
Camp Hill, Pennsylvania
Kaushal Patel, MD, has no financial interests/relationships or affiliations in relation to this activity.
Nurse Reviewer
Tracy L. Greene, MSN, RN, NP-C
Consultant
Tampa, Florida
Tracy L. Greene, MSN, RN, NP-C, has no financial interests/relationships or affiliations in relation to this activity.
CPE Reviewer
Nancy Nesser, JD, PharmD
Oklahoma Health Care Authority
Oklahoma City, Oklahoma
Nancy Nesser, JD, PharmD, has no financial interests/relationships or affiliations in relation to this activity.
Medical Director
Kate Nelson, PhD
PVI, PeerView Institute for Medical Education
Kate Nelson, PhD, has no financial interests/relationships or affiliations in relation to this activity.
Disclaimer
The information provided at this CME/MOC/CE/CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
Providership, Credit & Support
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME’s Program Reporting and Activity System (PARS). Individual or aggregated participant data may be shared with the funder of the activity.
Nurses
Medical Learning Institute, Inc.
Provider approved by the California Board of Registered Nursing, Provider Number 15106, for 1.0 contact hour(s).
Pharmacists
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this knowledge-based activity provides for 0.5 contact hours (0.05 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-17-019-H01-P.
Providership
This CME/MOC/CE/CPE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
Support
This educational activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.
About This CME/MOC/CE/CPE Activity
PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.
Copyright © 2000-2018, PeerView
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.
